vitamin D3
FDA Approved
Description
Vitamin D supplementation critical for bone health and calcium metabolism in skeletal dysplasias. Used in management of brachydactyly and bone dysplasias to optimize bone mineralization and support skeletal development.
Indications & Therapeutic Use
vitamin D deficiency, bone health support, skeletal dysplasias, rickets prevention
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
vitamin D3
| Generic Name | vitamin D3 |
| Brands | 1 brand available |
| Active Ingredient | cholecalciferol |
| Drug Class | vitamin D deficiency |
| Manufacturer | various |
| Dosage Forms | oral capsule 1000IU, 2000IU, 5000IU; liquid drops 400IU/drop |
| Medical Code | A11CC05 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 3 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes